BARCLAYS PLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,067
-99.9%
2,332,719
+16.9%
0.00%
-66.7%
Q3 2022$3,132,000
+834.9%
1,995,651
+1097.7%
0.00%
Q2 2022$335,000
+183.9%
166,620
+227.6%
0.00%
Q1 2022$118,000
-96.6%
50,859
-93.3%
0.00%
-100.0%
Q4 2021$3,520,000
+239.1%
756,858
+456.6%
0.00%
Q3 2021$1,038,000
+153.2%
135,978
+221.4%
0.00%
Q2 2021$410,000
-76.4%
42,302
-79.8%
0.00%
-100.0%
Q1 2021$1,736,000
-23.2%
209,898
-36.6%
0.00%0.0%
Q4 2020$2,260,000
-43.5%
331,104
-7.7%
0.00%
-50.0%
Q3 2020$4,000,000
+65.8%
358,863
-6.6%
0.00%0.0%
Q2 2020$2,413,000
+517.1%
384,276
+81.1%
0.00%
Q1 2020$391,000
-45.4%
212,205
+0.2%
0.00%
Q4 2019$716,000
+249.3%
211,685
+121.5%
0.00%
Q3 2019$205,000
+2.0%
95,578
+26.7%
0.00%
Q2 2019$201,000
+30.5%
75,416
+132.5%
0.00%
Q1 2019$154,000
-38.2%
32,431
-68.7%
0.00%
Q4 2018$249,000
-30.6%
103,672
+27.2%
0.00%
Q3 2018$359,000
+34.5%
81,515
+119.8%
0.00%
Q2 2018$267,000
-50.8%
37,079
-64.9%
0.00%
Q1 2018$543,000
+29.6%
105,500
-4.2%
0.00%
Q4 2017$419,000
+705.8%
110,144
+258.8%
0.00%
Q3 2017$52,000
-3.7%
30,700
+13.7%
0.00%
Q2 2017$54,000
+800.0%
27,000
+1739.2%
0.00%
Q1 2017$6,000
+100.0%
1,468
+127.2%
0.00%
Q4 2016$3,000
-50.0%
646
-35.4%
0.00%
Q2 2014$6,0001,0000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 5,216,250$4,621,5981.04%
B. Riley Securities, Inc. 5,216,250$4,621,5981.00%
EMFO, LLC 209,398$185,5270.19%
Wellspring Financial Advisors, LLC 483,551$428,4260.14%
Mayo Clinic 300,000$267,0000.14%
swisspartners Ltd. 110,000$97,4650.12%
Donald L. Hagan, LLC 169,514$150,1890.09%
Oaktree Fund Advisors, LLC 66,000$58,4760.09%
EUDAIMONIA ADVISORS LLC 138,887$123,0540.08%
Asset Management Resources, LLC 138,020$122,2860.08%
View complete list of SORRENTO THERAPEUTICS INC shareholders